High Incidence of Thromboembolic Events in Left Ventricular Assist Device Patients Treated With Recombinant Activated Factor VII

Journal of Heart and Lung Transplantation

Volumn 28, Issue 8, 2009, Pages 785-790

  Bruckner, Brian A ^a   DiBardino, Daniel J ^a   Ning, Qian ^b   Adeboygeun, Alfred ^b   Mahmoud, Karim ^b   Valdes, Jamie ^b   Eze, John ^b   Allison, Paul M ^b   Cooley, Denton A ^b   Gregoric, Igor D ^b   Frazier, Oscar H ^b  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b ST LUKE S EPISCOPAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ADOLESCENT; ADULT; AGED; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD VESSEL OCCLUSION; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; HEART ASSIST DEVICE; HEART INFARCTION; HUMAN; LABORATORY TEST; LOW DRUG DOSE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PARTIAL THROMBOPLASTIN TIME; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROTHROMBIN TIME; STROKE; THROMBOEMBOLISM;

ADOLESCENT; ADULT; AGED; BLOOD LOSS, SURGICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FACTOR VIIA; FEMALE; HEART-ASSIST DEVICES; HEMATOLOGIC AGENTS; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 67650732055     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2009.04.028     Document Type: Article

References (19)

1. Aggarwal A., Malkovska V., Catlett J.P., and Alcorn K. Recombinant activated factor VII (rFVIIa) as salvage treatment for intractable hemorrhage. Thromb J 2 (2004) 9
2. Boffard K.D., Riou B., Warren B., et al. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma 59 (2005) 8-15
3. Filsoufi F., Castillo J.G., Rahmanian P.B., Scurlock C., Fischer G., and Adams D.H. Effective management of refractory postcardiotomy bleeding with the use of recombinant activated factor VII. Ann Thorac Surg 82 (2006) 1779-1783
4. Friederich P.W., Henny C.P., Messelink E.J., et al. Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial. Lancet 361 (2003) 201-205
5. Mayer S.A., Brun N.C., Begtrup K., et al. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 352 (2005) 777-785
6. Payne E.M., Brett S.J., and Laffan M.A. Efficacy of recombinant activated factor VII in unselected patients with uncontrolled haemorrhage: a single centre experience. Blood Coagul Fibrinolysis 17 (2006) 397-402
7. Raivio P., Suojaranta-Ylinen R., and Kuitunen A.H. Recombinant factor VIIa in the treatment of postoperative hemorrhage after cardiac surgery. Ann Thorac Surg 80 (2005) 66-71
8. Rizoli S.B., Boffard K.D., Riou B., et al. Recombinant activated factor VII as an adjunctive therapy for bleeding control in severe trauma patients with coagulopathy: subgroup analysis from two randomized trials. Crit Care 10 (2006) R178
9. Sheth K.N. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 352 (2005) 2133-2134
10. O'Connell K.A., Wood J.J., Wise R.P., Lozier J.N., and Braun M.M. Thromboembolic adverse events after use of recombinant human coagulation factor VIIa. JAMA 295 (2006) 293-298
11. White M.C., Pryn S.J., and Monk C.R. Thrombogenic side-effects of recombinant factor VIIa after use in coronary artery bypass surgery. Anaesth Intensive Care 34 (2006) 664-667
12. Kenet G. High-dose recombinant factor VIIa therapy in hemophilia patients with inhibitors. Semin Hematol 43 suppl (2006) S108-S110
13. Kogan A., Berman M., Kassif Y., et al. Use of recombinant factor VII to control bleeding in a patient supported by right ventricular assist device after heart transplantation. J Heart Lung Transplant 24 (2005) 347-349
14. Apostolidou I., Sweeney M.F., Missov E., Joyce L.D., John R., and Prielipp R.C. Acute left atrial thrombus after recombinant factor VIIa administration during left ventricular assist device implantation in a patient with heparin-induced thrombocytopenia. Anesth Analg 106 (2008) 404-408
15. Gandhi M.J., Pierce R.A., Zhang L., Moon M.R., Despotis G.J., and Moazami N. Use of activated recombinant factor VII for severe coagulopathy post ventricular assist device or orthotopic heart transplant. J Cardiothorac Surg 2 (2007) 32
16. Altman R., Scazziota A., De Lourdes Herrera M., and Gonzalez C. Recombinant factor VIIa reverses the inhibitory effect of aspirin or aspirin plus clopidogrel on in vitro thrombin generation. J Thromb Haemost 4 (2006) 2022-2027
17. Romagnoli S., Bevilacqua S., Gelsomino S., et al. Small-dose recombinant activated factor VII (NovoSeven) in cardiac surgery. Anesth Analg 102 (2006) 1320-1326
18. Karkouti K., Beattie W.S., Wijeysundera D.N., et al. Recombinant factor VIIa for intractable blood loss after cardiac surgery: a propensity score-matched case-control analysis. Transfusion (Paris) 45 (2005) 26-34
19. MacLaren R., Weber L.A., Brake H., Gardner M.A., and Tanzi M. A multicenter assessment of recombinant factor VIIa off-label usage: clinical experiences and associated outcomes. Transfusion (Paris) 45 (2005) 1434-1442